Amgen Drug for Aggressive Type of Lung Cancer Wins Accelerated FDA Approval - MedCity NewsFDA approved a new Amgen drug, Imdelltra, for second-line treatment of small cell lung cancer, offering patients another option.
New era of medicine breaks through against the most aggressive lung cancerNew drugs offer hope for small cell lung cancer treatment.